Jennifer Capuzela | Director of Investor Relation |
Brett Monia | Founder, CEO & Director |
Beth Hougen | Chief Financial Officer |
Richard Geary | EVP & Chief Development Officer |
Onaiza Cadoret-Manier | EVP and Chief Corporate Development & Commercial Officer |
Eric Swayze | EVP of Research |
Yale Jen | Laidlaw & Co |
Chi Meng Fong | BofA Securities |
Yanan Zhu | Wells Fargo |
Esther Rajavelu | UBS |
Brendan Mychal Smith | Cowen and Company |
Josh Schimmer | Evercore ISI |
Gary Nachman | BMO Capital Markets |
Jessica Fye | JPMorgan |
Joseph Stringer | Needham & Co |
Luca Issi | RBC |
Good day, and welcome to the Ionis Pharmaceuticals Third Quarter 2021 Financial Results Conference Call.
As a reminder, this call is being recorded. And at this time, I would now like to turn the call over to Jennifer Capuzela. Please go ahead.
Thank you, Tom.